Chugai Pharmaceutical Co (JP:4519) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Chugai Pharmaceutical Co. reports that its performance for the first half of 2024 has been included in the half-year results announced by its parent company, Roche Holding Ltd. Roche, which owns 59.89% of Chugai’s issued shares and 61.12% of its voting rights, released these results covering January to June 2024. Investors can access further details on Roche’s website.
For further insights into JP:4519 stock, check out TipRanks’ Stock Analysis page.